Solid Biosciences (SLDB) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts SLDB Hot Sheet
Join SI Premium – FREE
Solid Biosciences (NASDAQ: SLDB) reported Q2 EPS of ($0.38), $0.07 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Endava PLC (ADR) (DAVA) to Underperform
- Jefferies Starts Crane NXT (CXT) at Buy
- Chevron (CVX) call put ratio 1 call 1 put amid wide oil price movement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
